Posters

Clinical outcomes of bioptics for residual refractive error correction after cataract surgery with multifocal intraocular lens implantation

Poster Details

First Author: B.Ko SOUTH KOREA

Co Author(s):    J. Kim                    

Abstract Details

Purpose:

To evaluate visual and refractive outcomes of bioptics for residual refractive error correction after cataract surgery with multifocal intraocular lens(IOL) implantation

Setting:

Apgujeong Eye Center, Seoul, South Korea

Methods:

A retrospective study comprised eyes of consecutive patients who had PRK or LASIK  using the VisuMax femtosecond laser and MEL 80 excimer laser to correct residual refractive error after multifocal intraocular lens implantation. 103 eyes of 78 patients(LASIK: 59, PRK: 40 and flap lift for LASIK retreatment: 4) were included in this study.

Results:

A statistically significant improvement was observed in uncorrected distance visual acuity(UCVA) (P<.01) and uncorrected near visual acuity(UCNVA) (p<.01) at six months after surgery. In LASIK group, 94.2%of eyes had an UCVA of 0.8 decimal or better, 92.9% had an UCNVA of J2 or better. In PRK group, 93.5%of eyes had an UCVA of 0.8 decimal or better, 92.5% had an UCNVA of J2 or better. There was no significant difference in postoperative UCVA or UCNVA between LASIK and PRK groups. No statistically significant differences were detected in spherical equivalent, sphere, or cylinder among groups. No adverse events reported.

Conclusions:

LASIK and PRK are effective and safe to correct residual ametropia after cataract surgery with multifocal IOL implantation

Financial Disclosure:

None